Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence

Takehiro Kawashiri, Keisuke Mine, Daisuke Kobayashi, Mizuki Inoue, Soichiro Ushio, Mayako Uchida, Nobuaki Egashira, Takao Shimazoe

Research output: Contribution to journalReview articlepeer-review

14 Citations (Scopus)


Oxaliplatin is an essential drug in the chemotherapy of colorectal, gastric, and pancreatic cancers, but it frequently causes peripheral neuropathy as a dose-limiting factor. So far, animal models of oxaliplatin-induced peripheral neuropathy have been established. The mechanisms of development of neuropathy induced by oxaliplatin have been elucidated, and many drugs and agents have been proven to have neuroprotective effects in basic studies. In addition, some of these drugs have been validated in clinical studies for their inhibitory effects on neuropathy. In this review, we summarize the basic and clinical evidence for the therapeutic effects of oxaliplatin. In basic research, there are many reports of neuropathy inhibitors that target oxidative stress, inflammatory response, sodium channel, transient receptor potential (TRP) channel, glutamate nervous system, and monoamine nervous system. Alternatively, very few drugs have clearly demonstrated the efficacy for oxaliplatin-induced peripheral neuropathy in clinical trials. It is important to activate translational research in order to translate basic research into clinical research.

Original languageEnglish
Article number1393
Pages (from-to)1-25
Number of pages25
JournalInternational journal of molecular sciences
Issue number3
Publication statusPublished - Feb 2 2021


  • Adverse effects
  • Clinical evidence
  • Oxaliplatin
  • Peripheral neuropathy
  • Preclinical data

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry


Dive into the research topics of 'Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence'. Together they form a unique fingerprint.

Cite this